Market for patented products will be concentrated in five therapeutic areas where Anti-cancer and neuropsychiatry account for around 45% of the global pipeline of new drugs. By 2015 these five therapies to contribute 60 to 70 percent of total patent product launches

 

Share of Global  pipeline by therapeutic areas*

Percentage

Anti-cancer

27

Central nervous system 17
Anti-infective 10
Gastro-intestinal 10
Cardiovascular 7
others 29
*excluding pre-clinical  Source: Pharmaprojects : Mckinsey analysis